Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules-Reference-Cited by-同舟云学术

Comparison of efficacy of SHENQI compound and rosiglitazone in the treatment of diabetic vasculopathy analyzing multi-factor mediated disease-causing modules

Published:2018-12-06 Issue:12 Volume:13 Page:e0207683
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Gao Hong^ORCID,Duan Yuhong^ORCID,Fu Xiaoxu^ORCID,Xie Hongyan^ORCID,Liu Ya^ORCID,Yuan Haipo^ORCID,Zhou Mingyang^ORCID,Xie Chunguang^ORCID

Funder

National Natural Science Foundation of China

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. Update on diabetic macroangiopathy;J Kunz;Der Pathologe,2012

2. Diabetic macrovascular complications;S Yamagishi;Nihon rinsho Japanese journal of clinical medicine,2015

3. Plasma levels of endothelin, lipid peroxides and prostacyclin in diabetic patients with macroangiopathy;IN Migdalis;Diabetes research and clinical practice,2001

4. Involvement of CaSR in hyperglycemia-induced macroangiopathy and related mechanism. Journal of Huazhong University of Science and Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao;JP Lu;Yixue Yingdewen ban,2015

5. Role of proinflammatory cytokines in the development and progression of micro- and macroangiopathies in patients with type 2 diabetes mellitus;AA Nelaeva;Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eriodictyol downregulates UBA52 to promote autophagy and upregulates Nrf2/HO-1 to inhibit oxidative stress to ameliorate non-alcoholic fatty liver disease;Journal of Functional Foods;2024-02

2. Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial;Frontiers in Cardiovascular Medicine;2024-01-08

3. Retinol binding protein 4 promotes the phenotypic transformation of vascular smooth muscle cells under high glucose condition via modulating RhoA/ROCK1 pathway;Translational Research;2023-09

4. Preliminary Study of the Distinctive Mechanism of Shenqi Compound in Treating Rats with Type 2 Diabetes Mellitus by Comparing with Metformin;Current Vascular Pharmacology;2023-03

5. Key circRNAs, lncRNAs, and mRNAs of ShenQi Compound in Protecting Vascular Endothelial Cells From High Glucose Identified by Whole Transcriptome Sequencing;Journal of Cardiovascular Pharmacology;2023-01-25